Johnson &amp; Johnson today announced the selection of a lead COVID-19 vaccine candidate from constructs it has been working on since January 2020 .
Image/qimono  They expect to initiate human clinical studies at the latest by September 2020 and anticipates the first batches of a COVID-19 vaccine could be available for emergency use authorization in early 2021 .
The company said its goal was to create 1 billion doses of the vaccine , a scale-up made possible by a partnership with the Biomedical Advanced Research and Development Authority ( BARDA ) .
Alex Gorsky , Chairman and Chief Executive Officer , Johnson &amp; Johnson , said , " The world is facing an urgent public health crisis and we are committed to doing our part to make a COVID-19 vaccine available and affordable globally as quickly as possible .
As the world 's largest healthcare company , we feel a deep responsibility to improve the health of people around the world every day .
Johnson &amp; Johnson is well positioned through our combination of scientific expertise , operational scale and financial strength to bring our resources in collaboration with others to accelerate the fight @ @ @ @ @ @ @ @ @ @ to provide you with the best browsing experience .
Find out more or adjust your settings .
Privacy Overview  This website uses cookies so that we can provide you with the best user experience possible .
Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful .
Strictly Necessary Cookies  Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings .
disable  If you disable this cookie , we will not be able to save your preferences .
This means that every time you visit this website you will need to enable or disable cookies again .
